DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to Covaxin, ZyCov-D and Corbevax
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Corbevax
Government panel recommends Corbevax for emergency use in kids aged five to 11 years
Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years
Corbevax to cost Rs 990 in market and Rs 145 for government
Biological E said that it is providing the most affordable COVID vaccine on a global scale due to process of innovation,…
Government releases guidelines for COVID vaccination of children in 12-14 years of age
Two doses of Biological E’s intramuscular vaccine Corbevax would be administered to the beneficiaries in the 12-14 years age group…
Biological E seeks EUA for Corbevax for children in five-12 age group
Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19
Decision on mixing and matching of booster dose of COVID vaccines will be based on science:…
Addressing a press conference, V K Paul, member (health), NITI Aayog, said studies are going on regarding the mixing and matching…
COVID-19 vaccine from Biological E.,CORBEVAX gets EUA from DCGI for 12-18 age group
DCGI has already approved CORBEVAX for restricted use in emergency situation among adults
Centre places purchase order for five crore doses of Corbevax COVID vaccine each costing Rs 145 sans…
The government is yet to decide on which segment of beneficiaries this new vaccine would be administered
Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022
Soon, the company plans to deliver more than one billion additional doses globally
Health ministry approves Corbevax, Covovax and Molnupiravir for restricted use in emergency…
CDSCO has received total of 22 applications for manufacturing and marketing of the drug Molnupiravir in the country